CA2588195C - Novel antiviral and immune stimulant pharmaceutical composition - Google Patents
Novel antiviral and immune stimulant pharmaceutical composition Download PDFInfo
- Publication number
- CA2588195C CA2588195C CA2588195A CA2588195A CA2588195C CA 2588195 C CA2588195 C CA 2588195C CA 2588195 A CA2588195 A CA 2588195A CA 2588195 A CA2588195 A CA 2588195A CA 2588195 C CA2588195 C CA 2588195C
- Authority
- CA
- Canada
- Prior art keywords
- pharmaceutical composition
- novel antiviral
- acid ester
- immune stimulant
- mass
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000000840 anti-viral effect Effects 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229960001438 immunostimulant agent Drugs 0.000 title 1
- -1 fatty acid ester Chemical class 0.000 abstract 3
- 241001565477 Aphyosemion omega Species 0.000 abstract 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 abstract 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 239000012141 concentrate Substances 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 235000021323 fish oil Nutrition 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000011669 selenium Substances 0.000 abstract 1
- 229910052711 selenium Inorganic materials 0.000 abstract 1
- 229940065287 selenium compound Drugs 0.000 abstract 1
- 150000003343 selenium compounds Chemical class 0.000 abstract 1
- 150000003751 zinc Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0402490A HU227588B1 (hu) | 2004-12-03 | 2004-12-03 | Többszörösen telítetlen zsírsavak észtereit tartalmazó vírusellenes és immunstimuláns gyógyászati készítmény |
| HUP0402490 | 2004-12-03 | ||
| PCT/HU2005/000122 WO2006059169A2 (en) | 2004-12-03 | 2005-11-15 | Antiviral and immunostimulating marine fish oil composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2588195A1 CA2588195A1 (en) | 2006-06-08 |
| CA2588195C true CA2588195C (en) | 2014-12-23 |
Family
ID=89985663
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2588195A Expired - Fee Related CA2588195C (en) | 2004-12-03 | 2005-11-15 | Novel antiviral and immune stimulant pharmaceutical composition |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9381213B2 (enExample) |
| EP (1) | EP1830861B1 (enExample) |
| JP (1) | JP4976307B2 (enExample) |
| KR (1) | KR101263963B1 (enExample) |
| CN (1) | CN101068540B (enExample) |
| AT (1) | ATE429236T1 (enExample) |
| CA (1) | CA2588195C (enExample) |
| DE (1) | DE602005014142D1 (enExample) |
| DK (1) | DK1830861T3 (enExample) |
| ES (1) | ES2326091T3 (enExample) |
| HU (1) | HU227588B1 (enExample) |
| PL (1) | PL1830861T3 (enExample) |
| WO (1) | WO2006059169A2 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL1800675T4 (pl) * | 2005-12-23 | 2012-02-29 | Nutricia Nv | Kompozycja zawierająca wielonienasycone kwasy tłuszczowe, białka, mangan, i/lub molibden oraz nukleozydy/nukleotydy do leczenia otępienia |
| MX350088B (es) * | 2009-04-29 | 2017-08-25 | Amarin Pharma Inc | Composicion farmaceutica estable y metodos de uso de la misma. |
| JP5710150B2 (ja) * | 2010-04-08 | 2015-04-30 | 持田製薬株式会社 | 潜伏性感染疾患の再発抑制剤 |
| JP2012149000A (ja) * | 2011-01-18 | 2012-08-09 | Junsei Educational Institution | 免疫賦活剤ならびにこれを含む食品および医薬組成物 |
| EP3248467A1 (de) | 2016-05-25 | 2017-11-29 | Evonik Technochemie GmbH | Verfahren zur herstellung einer zusammensetzung enthaltend omega-3-fettsäure-l-lysin-salze |
| CN114072155A (zh) * | 2019-04-01 | 2022-02-18 | 豪恩·西蒙·夏 | 用于癌症免疫疗法的组合物和方法 |
| AU2021324673B2 (en) * | 2020-08-10 | 2025-07-24 | Houn Simon Hsia | Compositions and methods for treating viral infection |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU209973B (en) | 1988-03-09 | 1995-01-30 | Biorex Kutato Fejlesztoe Kft | Process for production of antiviral and immunstimular pharmaceutical composition |
| HU199775B (en) * | 1988-03-09 | 1990-03-28 | Nagy Peter Literati | Process for production of formed by fatty acids salts of amin acids and medical compositions containing them |
| HU210122B (en) * | 1988-03-23 | 1995-02-28 | Biorex Kutato Fejlesztoe Kft | Process for production of composition against thromboembolytic conditions of circulating system and heart |
| IT1264987B1 (it) * | 1993-12-14 | 1996-10-17 | Prospa Bv | Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono |
| IT1274734B (it) * | 1994-08-25 | 1997-07-24 | Prospa Bv | Composizioni farmaceutiche contenenti acidi grassi poliinsaturi, loro esteri o sali, unitamente a vitamine o provitamine antiossidanti |
| EP0891771A1 (en) * | 1997-07-08 | 1999-01-20 | Health Now, Inc. | Compositions comprising lysine and ascorbate compounds for the treatment and prevention of cardiovascular diseases |
| KR100587551B1 (ko) * | 1997-12-10 | 2006-06-08 | 싸이클로스포린 테라퓨틱스 리미티드 | 오메가-3 지방산 오일을 함유하는 약학 조성물 |
| AT412758B (de) * | 2000-06-05 | 2005-07-25 | Vis Vitalis Lizenz & Handels | Verwendung einer selenithältigen lösung zur behandlung viraler erkrankungen |
| ES2386782T3 (es) * | 2002-03-08 | 2012-08-30 | Philera New Zealand Limited | Prevención y/o tratamiento de la enfermedad cardiovascular y/o la insuficiencia cardíaca asociada |
-
2004
- 2004-12-03 HU HU0402490A patent/HU227588B1/hu not_active IP Right Cessation
-
2005
- 2005-11-15 DE DE602005014142T patent/DE602005014142D1/de not_active Expired - Lifetime
- 2005-11-15 JP JP2007543938A patent/JP4976307B2/ja not_active Expired - Fee Related
- 2005-11-15 AT AT05808584T patent/ATE429236T1/de not_active IP Right Cessation
- 2005-11-15 ES ES05808584T patent/ES2326091T3/es not_active Expired - Lifetime
- 2005-11-15 CA CA2588195A patent/CA2588195C/en not_active Expired - Fee Related
- 2005-11-15 DK DK05808584T patent/DK1830861T3/da active
- 2005-11-15 US US11/792,247 patent/US9381213B2/en not_active Expired - Fee Related
- 2005-11-15 CN CN200580041636XA patent/CN101068540B/zh not_active Expired - Fee Related
- 2005-11-15 KR KR1020077014591A patent/KR101263963B1/ko not_active Expired - Fee Related
- 2005-11-15 PL PL05808584T patent/PL1830861T3/pl unknown
- 2005-11-15 WO PCT/HU2005/000122 patent/WO2006059169A2/en not_active Ceased
- 2005-11-15 EP EP05808584A patent/EP1830861B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CN101068540B (zh) | 2013-01-09 |
| JP2008521877A (ja) | 2008-06-26 |
| CA2588195A1 (en) | 2006-06-08 |
| EP1830861B1 (en) | 2009-04-22 |
| ATE429236T1 (de) | 2009-05-15 |
| KR101263963B1 (ko) | 2013-05-13 |
| US9381213B2 (en) | 2016-07-05 |
| JP4976307B2 (ja) | 2012-07-18 |
| US20080131519A1 (en) | 2008-06-05 |
| ES2326091T3 (es) | 2009-09-30 |
| HU227588B1 (hu) | 2011-09-28 |
| DK1830861T3 (da) | 2009-07-27 |
| KR20070086689A (ko) | 2007-08-27 |
| WO2006059169A2 (en) | 2006-06-08 |
| PL1830861T3 (pl) | 2009-09-30 |
| WO2006059169A3 (en) | 2007-02-22 |
| EP1830861A2 (en) | 2007-09-12 |
| HU0402490D0 (en) | 2005-02-28 |
| DE602005014142D1 (de) | 2009-06-04 |
| CN101068540A (zh) | 2007-11-07 |
| HUP0402490A2 (en) | 2009-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE332639T1 (de) | Herbizidzusammensetzung,umfassend herbizide verbindung in säureform und ansäuerndes mittel, applizierverfahren und herstellungsverfahren davon | |
| NZ516101A (en) | Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents | |
| BRPI0417043A (pt) | composição farmacêutica, forma de dosagem sólida, método de manufatura de forma de dosagem sólida, e, uso da composição | |
| ATE293367T1 (de) | Nahrungszusammensetzungen enthaltend methionin | |
| UA93879C2 (ru) | Гербицидная композиция c одной жидкой фазой | |
| CA2481848A1 (en) | Active ingredient particles carrying clopidogrel or a salt thereof, their use and method of preparation | |
| EA200700566A1 (ru) | Фармацевтические композиции, включающие леветирацетам, и способы их получения | |
| ATE453397T1 (de) | Probiotische tablettenformulierungen | |
| MX2009005299A (es) | Maiz extraido con solvente. | |
| TNSN05189A1 (en) | Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis | |
| TW200633716A (en) | Compositions and methods for stabilizing active pharmaceutical ingredients | |
| BRPI0508579A (pt) | composto, composição farmacêutica, e, uso de um composto | |
| UA86937C2 (ru) | Композиция, которая содержит лактат и калий, и ее применение | |
| MXPA02012889A (es) | Esteres de acidos 4-alcoxi-ciclohexano-1-amino-carboxilicos y procedimiento para su obtencion. | |
| HU0402490D0 (en) | New antiviral and immunstimulant pharmaceutical composition | |
| AR025320A1 (es) | Composicion liquida para mejorar el pan | |
| BRPI0417093A (pt) | composição para consumo animal, método para aumentar a palatabilidade de uma composição de ração, método para aumentar a ingestão de uma ração por um animal, processo para a preparação de uma composição para consumo animal, e, refeição e brinquedo para animal | |
| WO2004039326A3 (en) | Propofol with cysteine | |
| AU2003224107A1 (en) | Soluble composition containing sporopollenin and the use thereof | |
| TN2010000058A1 (fr) | Composition therapeutique aromatisee a base d'argile | |
| ATE412404T1 (de) | Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon | |
| PL1970372T3 (pl) | Sole kwasu 9-oksoakrydyno-10-octowego z 1-alkiloamino-1-deoksypoliolami | |
| WO2003068158A3 (en) | Compositions and methods for increasing milk production in animals | |
| JP2008521877A5 (enExample) | ||
| DE602004008440D1 (de) | Pharmazeutische kombinationspräparat zur behandlung von spastischkeit und/oder schmerzen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20221115 |